ProMIS Neurosciences, Inc. PMN
3.51 USD +0.22 (+6.69%)
As ofNov 16, 2026, 1:54 PM EST
3.15 Day range 3.49
2.78 52-week range 27.40
- YTD
- -48.61%
- 1 year
- -64.00%
News
benzinga.com ProMIS Neurosciences Q3 EPS $(0.89) Beats $(1.28) Estimate ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.89) per share which beat the analyst consensus estimate of $(1.28) by 30.47 percent. This is a 85.17 percent increase over losses of…
globenewswire.com ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing PRECISE-AD Phase 1b clinical trial in Alzheimer's patients remains on track for unblinded 12-month topline data in the first quarter of 2027, including full safety, biomarker and cognitive outcomes…benzinga.com Roth Capital Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $15 Roth Capital analyst Boobalan Pachaiyappan maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and lowers the price target from $29 to $15.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers CareDx (NASDAQ:CDNA) shares rose 22.2% to $87.42 during Friday's regular session. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday.…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 12.0% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $115.1 million. Intensity…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pomdoctor (NASDAQ:POM) stock moved upwards by 115.1% to $1.43 during Wednesday's regular session. The market value of their outstanding shares is at $4.9 million. Stablecoin Development…
